Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types
about
Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System?Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model.Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy).Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms TumorsCirculating tumor DNA (ctDNA) in the era of personalized cancer therapyGenomic profiling of synchronous triple primary tumors of the lung, thyroid and kidney in a young female patient: A case reportLiquid biopsy of cancer: a multimodal diagnostic tool in clinical oncologyFrom validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world settingShort-Term Responders of Non-Small Cell Lung Cancer Patients to EGFR Tyrosine Kinase Inhibitors Display High Prevalence of TP53 Mutations and Primary Resistance Mechanisms
P2860
Q47563363-F7CCEFBE-F5BE-4589-A8E4-6B021F40F50DQ48521971-8B6A31C9-5905-426C-93BD-2C0113843CC2Q49296229-5A34C624-ADA2-425D-9F63-92B707AE0613Q52673571-888C031B-EC6B-4B3E-8B9B-B95D344C0694Q55520820-5E2FA5AF-0850-42AF-A449-328F62C359ABQ56761473-2844DE60-D2B5-4EBD-9396-4D81611A6442Q57147396-B7FC0DD7-5569-443E-BC16-2904A8470A64Q57788698-53C24EA7-F93F-4D86-A8CE-9FBFB0322F9DQ58695249-9D14DD08-58A1-4A76-BA65-CC3E0D3A2AC6Q58757488-7CDBEBB4-6926-4A4A-9A97-BD4866F483A5Q58759414-8ADE6750-D3E9-4ACF-9A40-4A7A664F22D5
P2860
Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Circulating Tumor DNA Mutation ...... ments in Multiple Cancer Types
@ast
Circulating Tumor DNA Mutation ...... ments in Multiple Cancer Types
@en
type
label
Circulating Tumor DNA Mutation ...... ments in Multiple Cancer Types
@ast
Circulating Tumor DNA Mutation ...... ments in Multiple Cancer Types
@en
prefLabel
Circulating Tumor DNA Mutation ...... ments in Multiple Cancer Types
@ast
Circulating Tumor DNA Mutation ...... ments in Multiple Cancer Types
@en
P2093
P2860
P1433
P1476
Circulating Tumor DNA Mutation ...... ments in Multiple Cancer Types
@en
P2093
Chunrong Zhu
Huawu Shao
Liangjun Zhu
Xiaofeng Chen
Xiaoling Tong
Xiaonan Wang
Yang W Shao
Ying Liang
P2860
P2888
P356
10.1038/S41598-017-00520-1
P407
P50
P577
2017-04-03T00:00:00Z
P6179
1084130650